Literature DB >> 20959879

Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases.

Giovanni Cioffi1, Eva Gerdts, Dana Cramariuc, Luigi Tarantini, Andrea Di Lenarda, Giovanni Pulignano, Donatella Del Sindaco, Carlo Stefenelli, Giovanni de Simone.   

Abstract

BACKGROUND: Left atrial (LA) systolic force (LASF) is significantly increased in chronic heart failure (CHF), arterial hypertension (HT) and aortic stenosis (AS). The increase is proportional to the degree of left ventricular hypertrophy and diastolic dysfunction.
OBJECTIVES: To assess the magnitude of changes in maximal LA volume (LAV(max)) and LASF in systolic CHF compared with other cardiac diseases, and to assess whether the left atrium remodels differently and works in response to specific conditions affecting diastolic function and to individual factors associated with LA alterations.
METHODS: LAV(max) and LASF were measured and evaluated by two-dimensional Doppler echocardiography in 94 patients with systolic CHF and normal left ventricular filling pressure, 100 control patients, 181 patients with HT, 40 patients with idiopathic hypertrophic cardiomyopathy (HCMP) and 85 patients with AS. The prevalence of LA dilation and supernormal LASF (defined as values of LAV(max) and LASF exceeding two SDs of the mean of controls) was measured in all groups.
RESULTS: LAV(max) and LASF were 7.1±2 mL/m(3) and 7.8±4 kdynes in controls, and 11.0±4 mL/m(3) and 19.7±11 kdynes in systolic CHF patients, respectively (both P<0.001). These values were significantly higher than in patients with HT, but similar to those with AS and HCMP. LA dilation and supernormal LASF were detected in 13% and 11% of patients with HT, 32% and 59% of patients with AS, 26% and 43% of patients with HCMP, and 41% and 56% of patients with systolic CHF, respectively (all P<0.01). In multiple logistic analysis, systolic CHF represented the strongest predictor of supernormal LASF. It was not independently associated with LA dilation, which was mainly related to indexes of volume load.
CONCLUSIONS: LAV(max) and LASF were markedly increased in patients with systolic CHF, with a magnitude that was significantly higher than that of HT patients, but similar to that measured in HCMP and AS patients. In the present community population with various cardiac diseases, systolic CHF represented the most powerful stimulus for increasing LASF and was not related to LA dilation.

Entities:  

Keywords:  Aortic stenosis; Arterial hypertension; Chronic heart failure; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Left atrial systolic function

Year:  2010        PMID: 20959879      PMCID: PMC2954028     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  45 in total

1.  The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk.

Authors:  Pamela S Douglas
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Left atrial systolic function is depressed in idiopathic and preserved in ischemic dilated cardiomyopathy.

Authors:  F Triposkiadis; I Moyssakis; L Hadjinikolaou; T Makris; H Zioris; A Hatzizaharias; M Kyriakidis
Journal:  Eur J Clin Invest       Date:  1999-11       Impact factor: 4.686

3.  Noninvasive indexes of left atrial diastolic function in hypertrophic cardiomyopathy.

Authors:  P S Dardas; G S Filippatos; D D Tsikaderis; L K Michalis; I A Goudevenos; D A Sideris; L M Shapiro
Journal:  J Am Soc Echocardiogr       Date:  2000-09       Impact factor: 5.251

4.  Value of left atrial function in predicting exercise capacity in heart failure with moderate to severe left ventricular systolic dysfunction.

Authors:  Sait Terzi; Sennur Unal Dayi; Tamer Akbulut; Nurten Sayar; Tuba Bilsel; Burak Tangurek; Haldun Akgoz; Hacer Kose; Serdar Yilmazer; Kemal Yesilcimen
Journal:  Int Heart J       Date:  2005-01       Impact factor: 1.862

5.  Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension.

Authors:  Giovanni Cioffi; Gian Francesco Mureddu; Carlo Stefenelli; Giovanni de Simone
Journal:  J Hypertens       Date:  2004-08       Impact factor: 4.844

6.  Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension.

Authors:  G de Simone; R B Devereux; M J Roman; A Ganau; P S Saba; M H Alderman; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

7.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

8.  Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.

Authors:  Anne B Rossebø; Terje R Pedersen; Christopher Allen; Kurt Boman; John Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; V Antero Y Kesäniemi; William Malbecq; Christoph Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Journal:  Am J Cardiol       Date:  2007-02-15       Impact factor: 2.778

9.  Left atrial volume and function in valvular aortic stenosis.

Authors:  F Triposkiadis; C Pitsavos; H Boudoulas; A Trikas; I Kallikazaros; C Stefanadis; P Toutouzas
Journal:  J Heart Valve Dis       Date:  1993-01

10.  Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy.

Authors:  Andrea Rossi; Mariantonietta Cicoira; Luisa Zanolla; Rita Sandrini; Giorgio Golia; Piero Zardini; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

View more
  5 in total

1.  Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography.

Authors:  Antonella Cherubini; Giovanni Cioffi; Carmine Mazzone; Giorgio Faganello; Giulia Barbati; Luigi Tarantini; Giulia Russo; Carlo Stefenelli; Franco Humar; Eliana Grande; Maurizio Fisicaro; Claudio Pandullo; Andrea Di Lenarda
Journal:  Cardiovasc Ultrasound       Date:  2016-06-01       Impact factor: 2.062

2.  Different determinants of exercise capacity in HFpEF compared to HFrEF.

Authors:  Arlind Batalli; Pranvera Ibrahimi; Ibadete Bytyçi; Artan Ahmeti; Edmond Haliti; Shpend Elezi; Michael Y Henein; Gani Bajraktari
Journal:  Cardiovasc Ultrasound       Date:  2017-04-26       Impact factor: 2.062

3.  Association of left atrial volume index and all-cause mortality in patients referred for routine cardiovascular magnetic resonance: a multicenter study.

Authors:  Mohammad A Khan; Eric Y Yang; Yang Zhan; Robert M Judd; Wenyaw Chan; Faisal Nabi; John F Heitner; Raymond J Kim; Igor Klem; Sherif F Nagueh; Dipan J Shah
Journal:  J Cardiovasc Magn Reson       Date:  2019-01-07       Impact factor: 5.364

4.  Decreased Left Atrial Reservoir Strain Is Associated with Adverse Outcomes in Restrictive Cardiomyopathy.

Authors:  Jadranka Stojanovska; Nevriye Topaloglu; Kana Fujikura; Behnaz Khazai; El-Sayed Ibrahim; Alex Tsodikov; Nicole M Bhave; Theodore J Kolias
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

5.  Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction.

Authors:  Felix Hohendanner; Daniel Messroghli; David Bode; Florian Blaschke; Abdul Parwani; Leif-Hendrik Boldt; Frank R Heinzel
Journal:  ESC Heart Fail       Date:  2018-02-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.